Your browser doesn't support javascript.
loading
Adverse events risk associated with angiogenesis inhibitors addition to therapy in ovarian cancer: a meta-analysis of randomized controlled trials.
Liang, X-J; Shen, J.
Affiliation
  • Liang XJ; Department of Intensive Care Unit, Jinshan Hospital Fudan University, Jinshan District, Shanghai, P.R. China. jieshen20160101@sina.com.
Eur Rev Med Pharmacol Sci ; 20(12): 2701-9, 2016 06.
Article in En | MEDLINE | ID: mdl-27383326
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Randomized Controlled Trials as Topic / Angiogenesis Inhibitors Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Systematic_reviews Limits: Female / Humans Language: En Journal: Eur Rev Med Pharmacol Sci Journal subject: FARMACOLOGIA / TOXICOLOGIA Year: 2016 Document type: Article
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Randomized Controlled Trials as Topic / Angiogenesis Inhibitors Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Systematic_reviews Limits: Female / Humans Language: En Journal: Eur Rev Med Pharmacol Sci Journal subject: FARMACOLOGIA / TOXICOLOGIA Year: 2016 Document type: Article